From: Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer
Mutation
Amino acid
N
%
GGT → GAT
gly12 → asp12
5
29
GGT → TGT
gly12 → cys12
1
6
GGT → GTT
Gly12 → val12
GGT → GCT
gly12 → alanin12
2
12
GGT → AGT
gly12 → ser12
GGT → CGT
gly12 → arg12
GGT → GAC
gly13 → asp13
Total
17
100